: Personal Injury and Social Security Disability Blog
Glaxo Defends Handling of Avandia Heart Risks
By Robert Kraft
GlaxoSmithKline said this week that a Senate report criticizing its handling of heart risks with its diabetes drug Avandia "mischaracterizes and distorts" the company's record. As reported by the Associated Press, Glaxo is unhappy with the way the company's response to reports of heart attacks caused by Avandia have been characterized by the Food and Drug Administration and the Senate Finance Committee. The Senate report, issued over the weekend, charged that Glaxo downplayed the drug's safety risks and withheld important data from the FDA. "That suggestion is fundamentally flawed and contradicted by the record of extensive, ongoing interactions between GSK and the FDA," states the company.
A report in May 2007 showed that Avandia users had a 43% higher risk of heart attacks than patients taking other diabetes drugs or no diabetes drugs at all.
Avandia Heart Attack: Questions Still Remain Washington, DC: The Avandia debacle continues to daze and confuse in the face of conflicting information. GlaxoSmithKline (Glaxo), the makers of Avandia, continue to claim that studies conclude there is no risk of Avandia heart attack...
Glaxo Profits Anemic, Avandia Partly to Blame Washington, DC: It might be the largest pharmaceutical manufacturer in Europe, but GlaxoSmithKline (Glaxo) is in the midst of a restructuring, with job cuts on the horizon. While it has been reported there are many factors behind those struggles, Avandiaâ€”and its risks for heart attack and heart failureâ€”certainly aren't helping.
New Study Suggests Avandia Worse than Actos, Glaxo Cries Foul Toronto, ON: New research out of Canada pertaining to Avandia side effects and Avandia risks appears to suggest that patients taking Avandia have a greater chance for developing heart failure?and have a greater risk of death?than those taking rival type 2 diabetes drug Actos.
Don't Cry for Avandia Maker Glaxo Just Yet Philadelphia, PA: Profits may have been down in the first quarter when compared to a year ago, but the manufacturer of Avandia and gatekeeper of the Avandia recall appears to be holding its own...
Avandia Decline Not Affecting GlaxoSmithKline Philadelphia, PA: While profits may have been down in the first quarter when compared to a year ago, Avandia manufacturer GlaxoSmithKline (Glaxo) appears to be doing well. And while the risk for Avandia heart attack and other Avandia side effects continues for Type 2 diabetes patients-and critics continue to lobby for an Avandia recall-Glaxo's own health appears to be stable, if not robust.
Lawsuit Alleges GSK Bullied Avandia Critic Beaumont, TX: The question many people are asking as more lawsuits are filed against GlaxoSmithKline (GSK) regarding Avandia heart attacks is, how much did GSK know about the risks associated with its drug? Avandia side effects have proven to be very serious for many patients who took the diabetes drugâ€”more serious than those patients ever expected...
Brown Greer et al. alleging that the six law firms handling the Vioxx settlement failed to provide money for reimbursements to lien rights of Employee Retirement Income Security Act (ERISA) health plans.